Experts are divided over the impact of Medicare’s decision for Alzheimer’s drugs and other difficult diseases.
Related posts:
CDC chief warns of ‘impending doom’ as Covid cases surge
‘A tough call’: Biden considering mandatory Covid vaccines for U.S. troops
Obamacare supporters see opening to shore up law after court win
Opioid lawsuits on verge of settlements with 4 companies
NFL: Covid outbreaks among unvaccinated players could mean forfeits
VA sets vaccine requirement for frontline health care workers
Stubborn Covid surges signal bleak winter
House panel probing Covid response seeks to question former FDA chief
FDA gives full approval to Moderna’s Covid-19 shot
U.S. officials: Russian escalation in Ukraine could lead to humanitarian crisis
Federal dollars narrowed Covid-19 racial gaps. That may soon change.
BA.2 now dominant variant in the United States as funding fight continues
